Processes: Hydrolases EC 3-EC 3.1.1.3 to EC 3.4.17.2

Industrial Biotransformations, Second Edition

Volumn , Issue , 2006, Pages 273-349

  Liese, Andreas ^a   Seelbach, Karsten ^b   Buchholz, Arne ^c   Haberland, Jürgen ^c  

^a HAMBURG UNIVERSITY OF TECHNOLOGY   (Germany)

^b Siegwerk Druckfarben AG   (Germany)

^c DSM NUTRITIONAL PRODUCTS LTD   (Switzerland)

Author keywords

Hydrolases; Processes

Indexed keywords

EID: 84889350062     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1002/9783527608188.ch6c     Document Type: Chapter

References (81)

1. Balkenhohl, F., Hauer, B., Ladner, W., Schnell, U., Pressler, U., Staudenmaier, H.R. (1995) Lipase katalysierte Acylierung von Alkoholen mit Diketenen, BASF AG, DE 4329293 A1
2. Balkenhohl, F., Ditrich, K., Hauer, B., Ladner, W. (1997) Optisch aktive Amine durch Lipasekatalysierte Methoxyacetylierung, J. prakt. Chem. 339, 381-384
3. Reetz, M.T., Schimossek, K. (1996) Lipase-catalyzed dynamic kinetic resolution of chiral amines: use of palladium as the racemization catalyst, Chimia 50, 668-669
4. Holton, R.A. (1992) Method for preparation of taxol using ß-lactam, Florida State University, US 5,175,315
5. Patel, R.N., Szarka, L.J., Partyka, R.A. (1993) Enzymatic process for resolution of enantiomeric mixtures of compounds useful as intermediates in the preparation of taxanes, E.R. Squibb Sons & Inc., EP 552041 A2
6. Patel, R.N., Banerjee, A., Ko, R.Y., Howell, J.M., Li, W.-S., Comezoglu, F.T., Partyka, R.A., Szarka, L.J. (1994) Enzymic preparation of (3R-cis)-3-(acetyloxy)-4-phenyl-2-azetidinone: a taxol side-chain synthon, Biotechnol. Appl. Biochem. 20, 23-33
7. Zaks, A., Dodds, D.R. (1997) Application of biocatalysis and biotransformations to the synthesis of pharmaceuticals, Drug Discovery Today 2, 513-531
8. Patel, R.N. (1992) Enantioselective enzymatic acetylation of racemic [4-[4α,6β(E)]]-6-[4,4-bis(4-fluorophenyl])-3-(1-methyl-1H-tetrazol-5-yl)-1,3-butadienyl]-tetrahydro-4-hydroxy-2H-pyran-2-one, Appl. Microbiol. Biotechnol. 38, 56-60
9. Patel, R.N. (1997) Stereoselective biotransformations in synthesis of some pharmaceutical intermediates, Adv. Appl. Microbiol. 43, 91-140
10. McCague, R., Taylor, S.J.C. (1997) Dynamic resolution of an oxazolinone by lipase biocatalysis: Synthesis of (S)-tert-leucine, in: Chirality In Industry II (Collins, A.N., Sheldrake, G.N., Crosby, J., eds.), pp. 201-203, John Wiley & Sons, New York
11. Turner, N.J., Winterman, J.R., McCague, R., Parratt, J.S., Taylor, S.J.C. (1995) Synthesis of homochiral l-(S)-tert-leucine via a lipase catalysed dynamic resolution process, Tetrahedron Lett. 36, 1113-1116
12. Sheldon, R.A. (1993) Chirotechnology, Marcel Dekker Inc., New York
13. Elferink, V.H.M. (1995) Progress in the application of biocatalysis in the industrial scale manufacture of chiral molecules, Chiral USA 96, 11th International Spring Innovations Chirality Symposium, pp. 79-80
14. Boston Evans, C.T., Roberts, S.M., Shoberu, K.A., Sutherland, A.G. (1992) Potential use of carbocylic nucleosides for the treatment of AIDS: Chemo-enzymatic syntheses of the enantiomers of carbovir; J. Chem. Soc. Perkin Trans. 1, 589-592
15. MacKeith, R.A., McCague, R., Olivo, H.F., Palmer, C.F., Roberts, S.M. (1993) Conversion of (-)-4-hydroxy-2-oxabicyclo[3.3.0]oct-7-en-3-one into the anti-HIV agent Carbovir, J. Chem. Soc. Perkin Trans. 1 1, 313-314
16. MacKeith, R.A., McCague, R., Olivo, H.F., Roberts, S.M., Taylor, S.J.C., Xiong, H. (1994) Enzyme-catalysed kinetic resolution of 4-endo-hydroxy-2-oxabicyclo[3.3.0]oct-7-en-3-one and employment of the pure enantiomers for the synthesis of anti-viral and hypocholesteremic agents, Bioorg. Med. Chem. 2, 387-394
17. Taylor, S.J.C., McCague, R. (1997) Resolution of a versatile hydroxylactone synthon 4-endohydroxy-2-oxabicyclo[3.3.0]oct-7-en-3-one by lipase deesterification, in: Chirality In Industry II (Collins, A. N., Sheldrake, G. N. and Crosby, J., eds.), pp. 190-193, John Wiley & Sons, New York
18. Adams, S.S., Bresloff, P., Mason, C.G. (1976) Pharmacological differences between the optical isomers of ibuprofen: evidence for metabolic inversion of the (-)-isomer, J. Pharm. Pharmacol. 28, 256-257.
19. Cesti, P., Piccardi, P. (1986) Process for the biotechnological preparation of optically active α-arylalkanoic acids, Montedison S.p.A., Italy, EP 195717 A2
20. Lopez, J.L., Wald, S.A., Matson, S.L., Quinn, J.A. (1990) Multiphase membrane reactors for separating stereoisomers, Ann. N. Y. Acad. Sci., 613, 155-166
21. McConville, F.X., Lopez, J.L., Wald, S.A. (1990) Enzymatic resolution of ibuprofen in a multiphase membrane reactor, in: Biocatalysis (Abramowicz, D.A., ed.) pp.167-177, van Nostrand Reinhold, New York
22. Sheldon, R.A. (1993) Chirotechnology, Marcel Dekker Inc., New York
23. Sih, C. J. (1987) Process for preparing (S)-α-methylarylacetic acids, Wisconsin Alumni Research Foundation, USA, EP 227078 A1
24. Yamamoto, K., Ueno, Y., Otsubo, K., Kawakami, K., Komatsu, K.I. (1990) Production of (S)-(+)-ibuprofen from a nitrile compound by Acinetobacter sp. Strain AK226, Appl. Environ. Microbiol. 56, 3125-3129
25. Morgan, B., Dodds, D.R., Zaks, A., Andrews, D.R., Klesse, R. (1997) Enzymatic desymmetrization of prochiral 2-substituted-1,3-propanediols: A practical chemoenzymatic synthesis of a key precursor of SCH51048, a broad-spectrum orally active antifungal agent, J. Org. Chem. 62, 7736-7743
26. Morgan, B., Stockwell, B.R., Dodds, D.R., Andrews, D.R., Sudhakar, A.R., Nielsen, C.M., Mergelsberg, I., Zumbach, A. (1997) Chemoenzymatic approaches to SCH 56592, a new azole antifungal, J. Am. Oil Chem. Soc. 74, 1361-1370
27. Pantaleone, D.P. (1999) Biotransformations: "Green" processes for the synthesis of chiral fine chemicals, in: Handbook of Chiral Chemicals (Ager, D.J., ed.) pp. 245-286, Marcel Dekker Inc., New York
28. Saksena, A.K., Girijavallabhan, V.M., Pike, R.E., Wang, H., Lovey, R.G., Liu, Y.-T., Ganguly, A.K., Morgan, W.B., Zaks, A. (1995) Process for preparing intermediates for the synthesis of antifungal agents, Schering Corporation, US 5,403,937
29. Saksena, A.K., Girijavallabhan, V.M.,Wang, H., Liu, Y.-I., Pike, R.R., Ganguly, A.K. (1996) Concise asymmetric routes to 2,2,4-trisubstituted tetrahydrofurans via chiral titanium imide enolates: Key intermediates towards synthesis of highly active azole antifungals SCH 51048 and SCH 56592, Tetrahedron Lett. 37, 5657-5660
30. Zaks, A., Dodds, D.R. (1997) Application of biocatalysis and biotransformations to the synthesis of pharmaceuticals, Drug Discovery Today 2 (6), 513-531
31. Walsgrove, T.C., Powell, L., Wells, A. (2002) A practical and robust process to produce SB-2124857, Lotrafiban, [(2S)-7-(4,4'-bipiperidinylcarbonyl)-2,3,4,5,-tetrahydro-4-methyl-4-oxo-1H-1,4-benzodiazepine-2-acetic acid] utilising an enzymatic resolution as the final step, Org. Proc. Res. Dev. 6, 488-491
32. Stead, P., Marley, H., Mahmoudian, M., Webb, G., Noble, D., Ip, Y.T., Piga, E., Rossi, T., Roberts, S., Dawson, M.J. (1996) Efficient procedures for the large-scale preparation of (1S,2S)-trans-2-methoxycyclohexanol, a key chiral intermediate in the synthesis of tricyclic b-lactam antibiotics, Tetrahedron: Asymmetry 7 (8), 2247-2250
33. Hirohara, H., Nishizawa, M. (1998) Biochemical synthesis of several chemical insecticide intermediates and mechanism of action of relevant enzymes, Biosci. Biotechnol. Biochem. 62, 1-9
34. Elferink, V.H.M. (1996) Progress in the application of biocatalysts in the industrial scale manufacture of chiral molecules, Proc. 11th Int. Spring Innovations Chirality Symposium, USA
35. Kierkels, J.G.T., Peeters, W.P.H. (1994) Process for the enzymatic preparation of optically active transglycidic acid esters, DSM NV, EP 602740 A1
36. López, J.L., Matson, S.L., Stanley, T.J., Quinn, J.A. (1991) Liquid-liquid extractive membrane reactors, Bioproc. Technol. 11, 27-66
37. Matson, S.L. (1987) Method and apparatus for catalyst containment in multiphase membrane reactor systems, PCT WO 87/02381, PCT US 86/02089
38. Matsumane, H., Furui, M., Shibatani, T., Tosa, T. (1994) Production of optically active 3-phenylglycidic acid ester by the lipase from Serratia marcescens on a hollow-fiber membrane reactor, J. Ferment. Bioeng. 78, 59-63
39. Matsumane, H., Shibatani, T. (1994) Purification and characterization of the lipase from Serratia marcescens Sr41 8000 responsible for asymmetric hydrolysis of 3-phenylglycidic acid esters, J. Ferment. Bioeng. 77, 152-158
40. Tosa, T., Shibatani, T. (1995) Industrial application of immobilized biocatalysts in Japan, Ann. N. Y. Acad. Sci. 750, 364-375
41. Zaks, A., Dodds, D.R. (1997) Application of biocatalysis and biotransformations to the synthesis of pharmaceuticals, Drug Discovery Today, 2, 513-531
42. Patel, R.N. (2001) Enzymatic synthesis of chiral intermediates for drug development, Adv. Synth. Catal. 343, (6-7) 527-546
43. Patel, R.N., (2001) Enzymatic preparation of chiral pharmaceutical intermediates by lipases, J. Liposome Res. 11, (4) 355-393
44. Hills, G.A., McCrae, A.R., Poulina, R.R. (1990) Ester preparation, Unichema Chemie BV, EP 0383405 B1
45. Kemp, R.A., Macrae, A.R. (1992) Esterification process, Unichema Chemie BV, EP 0506159 A1
46. McCrae, A.R., Roehl, E.-L., Brand, H.M. (1990) Bio-Ester-Bio-Esters, Seifen-Öle-Fette-Wachse 116 (6), 201-205
47. Cheetham, P.S.J. (1994) Case studies in applied biocatalysis-from ideas to products, in: Applied Biocatalysis (Cabral, J.M.S., Best, D., Boross, L., Tramper, H., eds.) pp. 47-108, Harwood Academic Publishers
48. Chur Honda, Y., Kako, M., Abiko, K., Sogo, Y., (1993) Hydrolysis of lactose in milk, in: Industrial Application of Immobilized Biocatalysts (Tanaka, A., Tosa, T., Kobayashi, T., eds.) pp. 109-129, Marcel Dekker Inc., New York
49. Marconi, W., Morisi, F., (1979) Industrial application of fiber-entrapped enzymes, in: Appl. Biochem. Bioeng. 2, Enzyme Technology, (Wingard, L.B., Katchalski-Katzir, E., Goldstein, L., eds.) pp. 219-258, Academic Press, New York
50. Goswami, A., Howell, J.M., Hua, E.Y., Mirfakhrae K.D., Soumeillant, M.C., Swaminathan, S., Qian, X., Quiroz, F.A., Vu, T.C., Wang, X., Zheng, B., Kronenthal, D.R., Patel, R.N. (2001) Chemical and enzymatic resolution of (R,S)-N-(tert-butoxycarbonyl)-3-hydroxymethylpiperidine, Org. Proc. Res. Dev. 5, 415-420
51. Shimizu, H., Ogawa, J., Kataoka, M., Kobayashi, M. (1997) Screening of novel microbial enzymes for the production of biologically and chemically useful compounds, in: Advances in biochemical engineering biotechnology, Vol. 58: New Enzymes for Organic Synthesis (Scheper, T., ed.) pp. 45-88, Springer, New York
52. Aretz, W. (1998) Hoechst Marion Roussel, personal communication
53. Christ, C. (1995) Biochemical production of 7-aminocephalosporanic acid, in: Ullmann's Encyclopedia of Industrial Chemistry, Vol. B8 (Arpe, H.-J. ed.) pp. 240-241, VCH Verlagsgesellschaft, Weinheim
54. Verweij, J., Vroom, E.D. (1993) Industrial transformations of penicillins and cephalosporins, Rec. Trav. Chim. Pays-Bas 112 (2), 66-81
55. Matsumoto, K. (1993) Production of 6-APA, 7-ACA, and 7-ADCA by immobilized penicillin and cephalosporin amidases, in: Industrial Application of Immobilized Biocatalysts (Tanaka, A., Tosa, T., Kobayashi, T. eds.) pp. 67-88, Marcel Dekker Inc., New York
56. Christ, C. (1995) Biochemical production of 7-aminocephalosporanic acid, in: Ullmann's Encyclopedia of Industrial Chemistry, Vol. B8 (Arpe, H.-J. ed.) pp. 240-241, VCH Verlagsgesellschaft, Weinheim
57. Matsumoto, K. (1993) Production of 6-APA, 7-ACA, and 7-ADCA by immobilized penicillin and cephalosporin amidases, in: Industrial Application of Immobilized Biocatalysts (Tanaka, A, Tosa, T., Kobayashi, T. eds.) pp. 67-88, Marcel Dekker Inc., New York
58. Tsuzuki, K., Komatsu, K., Ichikawa, S., Shibuya, Y. (1989) Enzymatic synthesis of 7-aminocephalosporanic acid (7-ACA), Nippon Nogei Kagaku Kaishi 63 (12), 1847
59. Verweij, J., de Vroom, E. (1993) Industrial transformations of penicillins and cephalosporins, Rec. Trav. Chim. Pays-Bas 112 (2), 66-81
60. Gerhartz, W.(1990) Enzymes in Industry: Production and Applications, VCH, Weinheim
61. Holm, J., Bjoerck, I., Ostrowska, S., Eliasson, A.-C., Asp, N.-G., Larsson, K., Lundquist, I. (1983) Digestibility of amylose-lipid complexes in vitro and in vivo, Stärke, 35, 294-297.
62. Holm, J., Bjoerck, I., Eliasson, A.-C. (1985) Digestibility of amylose-lipid complexes in vitro and in vivo, Prog. Biotechnol., 1, 89-92
63. Kainuma, K.(1998) Applied glycoscience-past, present and future, Foods Food Ingredients J. Jpn., 178, 4-10
64. Labout, J.J.M. (1985) Conversion of liquefied starch into glucose using a novel glucoamylase system, Starch/Stärke, 37, 157-161
65. Shirae, H., Yokozeki, K., Uchiyama, M., Kubota, K. (1988) Enzymatic production of ribavirin from purine nucleosides by Brevibacterium acetylicum ATCC 954, Agric. Biol. Chem. 52, 1777-1784
66. Shirae, H., Yokozeki, K. (1991) Purification and properties of purine nucleoside phosphorylase from Brevibacterium acetylicum ATCC 954, Agric. Biol. Chem. 55, 493-499
67. Shirae, H., Yokozeki, K. (1991) Purifications and properties of orotidine phosphorolyzing enzyme and purine nucleoside phosphorylase from Erwinia carotovora AJ 2992, Agric. Biol. Chem. 55 (7), 1849-1857
68. Zaks, A., Dodds, D.R. (1997) Application of biocatalysis and biotransformations to the synthesis of pharmaceuticals, Drug Discovery Today 2, 513-531
69. Crosby, J. (1991) Synthesis of optically active compounds: A large scale perspective, Tetrahedron 47, 4789-4846
70. Kamphuis, J., Hermes, H.F.M., van Balken, J.A.M., Schoemaker, H.E., Boesten, W.H.J., Meijer, E.M., (1990) Chemo-enzymatic synthesis of enantiomerically pure alpha-H and alpha-alkyl alpha-amino acids and derivates, in: Amino acids: Chemistry, Biology, Medicine; (Lubec, G., Rosenthal, G.A., eds.) pp. 119-125, ESCOM Science Pupl., Leiden
71. Kamphuis, J., Meijer, E.M., Boesten, W.H.J., Sonke, T., van den Tweel, W.J.J., Schoemaker, H.E. (1992) New developments in the synthesis of natural and unnatural amino acids, in: Enzyme Engineering XI, Vol. 672 (Clark, D.S., Estell, D.A., eds.), pp. 510-527, Ann. N. Y. Acad. Sci.
72. Meijer, E.M., Boesten, W.H.J., Schoemaker, H.E., van Balken, J.A.M. (1985) Use of biocatalysts in the industrial production of speciality chemicals, in: Biocatalysis in Organic Synthesis, (Tramper, J., Van der Plas, H.C., Linko, P.), eds.) pp. 135-156 Elsevier, Amsterdam, The Netherlands
73. Schoemaker, H.E., Boesten, W.H.J., Kaptein, B., Hermes, H.F.M., Sonke, T., Broxterman, Q.B., van den Tweel, W.J.J., Kamphuis, J. (1992) Chemo-enzymatic synthesis of amino acids and derivatives, Pure & Appl. Chem. 64, 1171-1175
74. Sheldon, R.A. (1993) Chirotechnology, Marcel Dekker, New York
75. van den Tweel, W.J.J., van Dooren, T.J.G.M., de Jonge, P.H., Kaptein, B., Duchateau, A.L.L., Kamphuis, J. (1993) Ochrobactrum anthropi NCIMB 40321: a new biocatalyst with broad-spectrum L-specific amidase activity, Appl. Microbiol. Biotechnol. 39, 296-300
76. Frank, B.H., Chance, R.E. (1983) Two routes for producing human insulin utilizing recombinant DNA technology, Münch. Med. Wschr. 125, 14-20
77. Jørgensen, L.N., Rasmussen, E., Thomsen, B. (1989) HM(ge), Novo's biosynthetic insulin; Med. View. III, No. 4, 1-7
78. Ladisch, M.R., Kohlmann, K.L. (1992) Recombinant human insulin, Biotechnol. Prog. 8, 469-478
79. Frank, B.H., Chance, R.E. (1983) Two routes for producing human insulin utilizing recombinant DNA technology, Münch. Med. Wschr. 125, 14-20
80. Jørgensen, L.N., Rasmussen, E., Thomsen, B. (1989) HM(ge), Novo's biosynthetic insulin; Med. View. III, No. 4, 1-7
81. Ladisch, M.R., Kohlmann, K.L. (1992) Recombinant human insulin, Biotechnol. Prog. 8, 469-478